|

SY001 Clinical Trials

1 actively recruiting trial

Also known as: CAR-pMAC

Top Sponsors

  • Cell Origin Biotech (Hangzhou) Co., Ltd.1

Indications

  • Treatment Related Cancer1
  • Ovarian Cancer1
  • Cancer1

Other1 trial

SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.